You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 3
  • 76 Patients (PTS) with recurrent gynecologic cancer whose tumors have activating wnt pathway mutations respond better to DKN-01, a DICKKOPF-1 (DKK1) inhibitor

Citation Tools

Article menu

Download PDFPDF

E-Poster discussions
Poster Discussion with the Professor Station 1
IGCS19-0419
76 Patients (PTS) with recurrent gynecologic cancer whose tumors have activating wnt pathway mutations respond better to DKN-01, a DICKKOPF-1 (DKK1) inhibitor
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Arend R, Castro C, Matulonis U, et al
76 Patients (PTS) with recurrent gynecologic cancer whose tumors have activating wnt pathway mutations respond better to DKN-01, a DICKKOPF-1 (DKK1) inhibitor
International Journal of Gynecologic Cancer 2019;29:A40-A41.